| 标题 |
 Evaluating the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic and treatment response biomarkers in stage IV colorectal cancer patients |
| 备注 |
Oncology in Clinical Practice
💡 该求助存在备注，如果存在信息冲突，请以备注为准
|
| 网址 | |
| DOI |
10.5603/ocp.99934
doi
|
| 其它 |
A Allahyari, F Fallah, PB Taqanaki… - Oncology in Clinical …, 2025 - journals.viamedica.pl A Allahyari, F Fallah, PB Taqanaki, SP Tafti, MM Vakilzadeh, MM Nodeh, M Kamandi… Oncology in Clinical Practice, 2025•journals.viamedica.pl Introduction. Stage IV colorectal cancer presents significant challenges in prognosis and treatment response. Reliable biomarkers are critical for predicting outcomes and guiding treatment choices. This study evaluated the efficacy of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as such biomarkers. Material and methods. Conducted at a hematology department in Mashhad, Iran, this study involved 105 patients diagnosed with stage IV colorectal cancer. Participants underwent complete blood count … Abstract Introduction. Stage IV colorectal cancer presents significant challenges in prognosis and treatment response. Reliable biomarkers are critical for predicting |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
神勇映雁
渡人舟
无极微光
学术文献互助
lior
v0id
cdercder
核桃
实验室
OK
奔跑
印第安老斑鸠
研友_8RyB3Z
hgvj
skearthy
Nole
LUOCC
My_magnum_opus
科研狗
皖公网安备34019202002308
